Selected Grants
Liposomal Amphotericin B and Flucytosine Antifungal Strategies for Talaromycosis (LAmB-FAST) - R01
ResearchAdvisor · Awarded by National Institutes of Health · 2024 - 2031Engaging Cooperative Sites for Trial Acceleration, Trust, Innovation, and Capability (ECSTATIC)
ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2023 - 20282/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension-DCC
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2026Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency
ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2023 - 2025Towards optimizing diabetes management and diagnosis by personalizing HbA1c targets
ResearchPrincipal Investigator · Awarded by University of Cincinnati · 2023 - 2025Rediscover ICU
ResearchPrincipal Investigator · Awarded by Society of Critical Care Medicine · 2024 - 2024CURE ID
ResearchPrincipal Investigator · Awarded by Society of Critical Care Medicine · 2024 - 2024Sepsis-AKI Learning Lab
ResearchPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2023 - 2023External Relationships
- Association for Clinical and Translational Science
- Bioscape Digital
- CR Forum
- Emory University
- Journal of Clinical and Translational Science
- King Saud Bin Abdulaziz University for Health Sciences
- National Heart Lung and Blood Institute
- Oregon Health and Science University
- Rocket Pharma
- University of Wisconsin, Madison
- Vanderbilt University Medical Center
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.